Elevation Wealth Partners’s AbbVie ABBV Stock Holding History

Elevation Wealth Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.29M	Buy	5,109 +122	+2%	+$26.2K	0.39%	43
2026 Q1	$1.08M	Sell	4,987 -350	-7%	-$77.6K	0.39%	42
2025 Q4	$1.22M	Sell	5,337 -173	-3%	-$39.4K	0.43%	40
2025 Q3	$1.28M	Buy	5,510 +104	+2%	+$21.2K	0.46%	40
2025 Q2	$1M	Hold	5,406	–	–	0.4%	45
2025 Q1	$1.13M	Sell	5,406 -146	-3%	-$28.4K	0.49%	41
2024 Q4	$987K	Sell	5,552 -146	-3%	-$26.8K	0.42%	41
2024 Q3	$1.13M	Hold	5,698	–	–	0.48%	40
2024 Q2	$977K	Hold	5,698	–	–	0.46%	43
2024 Q1	$1.04M	Sell	5,698 -790	-12%	-$136K	0.52%	37
2023 Q4	$967K	Buy	6,488 +5,004	+337%	+$730K	0.58%	35
2023 Q3	$221K	Hold	1,484	–	–	0.19%	52
2023 Q2	$200K	Hold	1,484	–	–	0.17%	58
2023 Q1	$237K	Buy	+1,484	New	+$227K	0.22%	55

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

KeyBank National Association Cleveland, Ohio $30.4B AUM 27.51% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Elevation Wealth Partners's ABBV Position: Q2 2026 in Review

Elevation Wealth Partners increased its AbbVie (ABBV) stake by 2.4% in Q2 2026, buying an estimated $26.2K and bringing the position to 5,109 shares worth $1.29M. The position accounts for 0.39% of the portfolio, ranked #43.

Elevation Wealth Partners first reported a position in ABBV in Q1 2023 and has held it in 14 quarters since. 1,786 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Elevation Wealth Partners held 5,109 shares of AbbVie worth $1.29M as of Q2 2026.
Elevation Wealth Partners bought 122 AbbVie shares in Q2 2026, an estimated $26.2K.
AbbVie made up 0.39% of Elevation Wealth Partners's portfolio in Q2 2026, its #43 holding.
Elevation Wealth Partners first reported a position in AbbVie in Q1 2023 and has held it in 14 quarters since.
1,786 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Elevation Wealth Partners's 13F filing for Q2 2026, filed 8 Jul 2026.